Ptc Therapeutics Inc (PTCT)

R&D Expenses

$99.15M

Quarterly · Period ending: · USD

PTCT logo

PTCT R&D Expenses

Latest reported$99.15M
PTCT Quarterly R&D Expenses ($14.30M → $99.15M)
High-resolution chart · PNG

PTCT r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ptc Therapeutics Inc R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
99,150,000
100,873,000
133,127,999
100,158,000
112,990,000
108,973,000
124,770,000
161,412,000
132,169,000
116,129,000
121,353,000
164,212,000
185,874,000
195,124,000
188,694,000
165,462,000
157,263,000
140,078,000
149,844,000
130,845,000
125,482,000
134,513,000
118,013,000
92,998,000
176,525,000
90,107,000
81,831,000
63,076,000
59,979,000
52,566,000
53,647,000
54,368,000
32,607,000
31,363,000
29,234,000
30,024,000
30,835,000
27,363,000
26,011,000
31,396,000
28,827,000
31,399,000
35,048,000
30,640,000
28,190,000
27,938,000
26,871,000
18,765,000
18,313,000
15,889,000
15,020,029
13,886,196
14,712,091
11,256,828
9,450,082
10,466,454
11,919,000
14,303,333
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.